Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus.
about
Statin-induced rhabdomyolysis: a comprehensive review of case reports.Fusidic acid resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in a Taiwanese hospital.Use of the surgical wound infection model to determine the efficacious dosing regimen of retapamulin, a novel topical antibiotic.Fusidic acid resistance in Staphylococcus aureus.Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolatesNosocomial bacterial infections in Intensive Care Units. I: Organisms and mechanisms of antibiotic resistance.Management of healthcare-associated methicillin-resistant Staphylococcus aureus.Staphylococcus aureus resistance to topical antimicrobials in atopic dermatitis.Newer developments in the treatment of Gram-positive infections.Efforts to support the development of fusidic acid in the United States.Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns.In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.Genetic determinants of resistance to fusidic acid among clinical bacteremia isolates of Staphylococcus aureusGenetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus.Polymorphism in Commercial Sources of Fusidic Acid: A Comparative Study of the In Vitro Release Characteristics of Forms I and III from a Marketed Pharmaceutical Cream.Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus.Addition of fusidic acid impregnated bone cement to systemic teicoplanin therapy in the treatment of rat osteomyelitis.
P2860
Q33551640-8274D4C3-FD91-4E2C-822F-9596C954C723Q33898879-1CF7A5CF-717C-44F4-9A99-AE08D11E18AFQ34572086-04BB80B1-3707-44FB-8DDA-7A072984B8B6Q35622199-7BEE0887-8001-4678-90EE-4B9861D42FA8Q35805515-148E517D-E6E0-438C-8EA5-8AEAA2A1CBE0Q36237707-51977C05-5511-464A-91CE-825F11BD67C6Q36322109-F48E1308-0860-474C-9571-E851080507ECQ37380234-A8F25089-86E6-4C4F-9433-3931E7B7DB7DQ37636151-A777DEBA-BAE6-49BD-A41A-B46009C5B4BAQ38428027-16CE305A-CF35-4D8F-8493-01AF24C9E7C0Q38673550-D41CC581-844D-4689-B6CE-3842B11A04CDQ39833267-AB07624C-1AFE-4F17-A084-749B5EC0F41CQ42111680-20AA216E-D14A-424E-8F18-CC70685E83F7Q42112074-542DEE85-2509-4895-9904-4A000CB1BC7AQ42718244-10B7D542-6D16-4E44-A8CF-9DA79DDFCE15Q43579575-29616AC1-20CA-46E4-BC59-D17904EA0793Q44839678-B8A189BA-2F5F-4D92-9FC1-68FF6BA13B59
P2860
Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus.
@ast
Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus.
@en
type
label
Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus.
@ast
Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus.
@en
prefLabel
Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus.
@ast
Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus.
@en
P1476
Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus.
@en
P2093
P304
P356
10.1016/S0924-8579(98)00075-2
P478
12 Suppl 2
P577
1999-08-01T00:00:00Z